Literature DB >> 1677272

Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines.

V Fleury1, E Anglés-Cano.   

Abstract

In the present study we have quantitatively characterized the interaction of purified human Glu- and Lys-plasminogen with intact and degraded fibrin by ligand-binding experiments using a radioisotopic dilution method and antibodies against human plasminogen. A fibrinogen monolayer was covalently linked to a solid support with polyglutaraldehyde and was treated with thrombin or with thrombin and then plasmin to respectively obtain intact and degraded fibrin surfaces. Under these conditions, a well-defined surface of fibrin is obtained (410 +/- 4 fmol/cm2) and, except for a 39-kDa fragment, most of the fibrin degradation products remain bound to the support. New binding sites for plasminogen were detected on the degraded surface of fibrin. These sites were identified as carboxy-terminal lysine residues both by inhibition of the binding by the lysine analogue 6-aminohexanoic acid and by carboxy-terminal end-group digestion with carboxypeptidase B. The binding curves exhibited a characteristic Langmuir adsorption isotherm saturation profile. The data were therefore analyzed accordingly, assuming a single-site binding model to simplify the analysis. Equilibrium dissociation constants (Kd) and the maximum number of binding sites (Bmax) were derived from linearized expression of the Langmuir isotherm equation. The Kd for the binding of Glu-plasminogen to intact fibrin was 0.99 +/- 0.17 microM and for degraded fibrin was 0.66 +/- 0.22 microM. The Kd for the binding of Lys-plasminogen to intact fibrin was 0.41 +/- 0.22 microM and for degraded fibrin was 0.51 +/- 0.12 microM.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677272     DOI: 10.1021/bi00244a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.

Authors:  O Klezovitch; C Edelstein; A M Scanu
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Ethnicity and lipoprotein(a) polymorphism in Native Mexican populations.

Authors:  G Cardoso-Saldaña; A De La Peña-Díaz; J Zamora-González; R Gomez-Ortega; C Posadas-Romero; R Izaguirre-Avila; E Malvido-Miranda; M E Morales-Anduaga; E Anglés-Cano
Journal:  Ann Hum Biol       Date:  2006 Mar-Apr       Impact factor: 1.533

3.  Thrombolysis by chemically modified coagulation factor Xa.

Authors:  E L G Pryzdial; S C Meixner; K Talbot; L J Eltringham-Smith; J R Baylis; F M H Lee; C J Kastrup; W P Sheffield
Journal:  J Thromb Haemost       Date:  2016-08-17       Impact factor: 5.824

4.  Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.

Authors:  Vincent Fontaine; Marie-Paule Jacob; Xavier Houard; Patrick Rossignol; Didier Plissonnier; Eduardo Angles-Cano; Jean-Baptiste Michel
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombus.

Authors:  Wei Zhang; Yong-Sheng Li; Michael A Nardi; Suying Dang; Jing Yang; Yong Ji; Zongdong Li; Simon Karpatkin; Thomas Wisniewski
Journal:  Blood       Date:  2010-06-04       Impact factor: 22.113

6.  Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity.

Authors:  J Parcq; T Bertrand; A Montagne; A F Baron; R Macrez; J M Billard; A Briens; Y Hommet; J Wu; M Yepes; H R Lijnen; P Dutar; E Anglés-Cano; D Vivien
Journal:  Cell Death Differ       Date:  2012-06-29       Impact factor: 15.828

7.  Fibrinolytic cross-talk: a new mechanism for plasmin formation.

Authors:  Tiphaine Dejouvencel; Loïc Doeuvre; Romaric Lacroix; Laurent Plawinski; Françoise Dignat-George; H Roger Lijnen; Eduardo Anglés-Cano
Journal:  Blood       Date:  2009-12-07       Impact factor: 22.113

8.  Plasma carboxypeptidases as regulators of the plasminogen system.

Authors:  A Redlitz; A K Tan; D L Eaton; E F Plow
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 9.  Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

Authors:  J L Willemse; E Heylen; M E Nesheim; D F Hendriks
Journal:  J Thromb Haemost       Date:  2009-08-28       Impact factor: 5.824

10.  Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets.

Authors:  V K Lishko; I S Yermolenko; T P Ugarova
Journal:  J Thromb Haemost       Date:  2009-01-22       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.